Disparities and Trends in Migraine Management in Pediatric Emergency Departments, 2009-19

Katia C Genadry1, Michael C Monuteaux1, Mark I Neuman1

  • 1Department of Pediatrics, Division of Emergency Medicine, Boston Children's Hospital, Harvard Medical School (KC Genadry, MC Monuteaux, MI Neuman, and LK Lee), Boston, Mass.

Academic Pediatrics
|May 24, 2022
PubMed

Insights

Migraine management in children evolved, with decreased opioid use and increased nonopioid medications. Clinical guidelines reduced opioid prescriptions, suggesting standardization can improve care equity.

Area of Science:

  • Pediatric Neurology
  • Health Services Research
  • Clinical Pharmacology

Background:

  • Migraine is a common neurological disorder in children and adolescents.
  • Management of pediatric migraine varies significantly across healthcare settings.
  • Understanding trends and disparities in migraine treatment is crucial for improving patient outcomes.

Purpose of the Study:

  • To analyze changes in migraine management strategies over time in US children's hospitals.
  • To identify factors contributing to variations and disparities in pediatric migraine care.
  • To evaluate the impact of clinical guidelines on treatment patterns.

Main Methods:

  • Retrospective analysis of 112,077 pediatric migraine visits (2009-2019) from the Pediatric Health Information System.
  • Survey of 32 hospitals regarding the presence of clinical guidelines for migraine management.
  • Multivariable logistic regression to assess medication and advanced imaging use based on patient demographics and guideline presence.

Main Results:

  • Opioid use for pediatric migraine decreased, while nonopioid analgesics, dopamine antagonists, and diphenhydramine use increased.
  • Older adolescents (14-21 years) had higher odds of opioid use; clinical guidelines were associated with decreased opioid use.
  • Hispanic ethnicity was linked to increased head CT use, while older age and female sex were associated with decreased head CT use.

Conclusions:

  • Pediatric migraine treatment has shifted towards nonopioid medications, with variations influenced by patient demographics and hospital guidelines.
  • Hospitals with clinical guidelines demonstrated reduced opioid prescribing for pediatric migraine.
  • Standardizing migraine management protocols may help mitigate disparities and improve consistency in care for pediatric patients.
Abstract